Osaka-based Maruho Co., Ltd has acquired Cutanea Life Sciences Inc., a U.S. private dermatology development company based in Pennsylvania. Maruho hopes to build up its dermatology business in the U.S. through CLS’s network and development capability. Maruho also gains access to CLS’s product pipeline and know-how in new drug discovery in the U.S. market. Since establishing its first U.S. local branch last year, Maruho has accelerated expansion in overseas markets. (Click here for more – Japanese language
Japanese Specialty Pharma Maruho Acquires Cutanea Of U.S.
Osaka-based Maruho Co., Ltd has acquired Cutanea Life Sciences Inc., a U.S. private dermatology development company based in Pennsylvania.